C.Q. Pharmaceutical Holding Co., Ltd. Sustainability Profile
C.Q. Pharmaceutical Holding Co., Ltd., commonly referred to as C.Q. Pharma, is a prominent player in the pharmaceutical industry, headquartered in China. Established in 2001, the company has made significant strides in the development and distribution of innovative healthcare solutions, primarily focusing on prescription medications and over-the-counter products. With a strong operational presence across Asia and expanding into international markets, C.Q. Pharma is dedicated to enhancing patient care through its diverse portfolio of high-quality pharmaceuticals. The company is recognised for its commitment to research and development, which has led to the introduction of unique formulations that address unmet medical needs. C.Q. Pharma's strategic position in the market is underscored by its achievements in regulatory compliance and partnerships, solidifying its reputation as a trusted provider in the global healthcare landscape.
DitchCarbon Score
How does C.Q. Pharmaceutical Holding Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
C.Q. Pharmaceutical Holding Co., Ltd.'s score of 22 is lower than 78% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
C.Q. Pharmaceutical Holding Co., Ltd.'s reported carbon emissions
C.Q. Pharmaceutical Holding Co., Ltd., headquartered in China (CN), currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary and does not inherit emissions data from a parent organization. In terms of climate commitments, there are no documented reduction targets or initiatives such as Science-Based Targets (SBTi) or other climate pledges. This lack of data suggests that C.Q. Pharmaceutical Holding Co., Ltd. may still be in the early stages of developing a comprehensive climate strategy or reporting framework. As the pharmaceutical industry increasingly focuses on sustainability, C.Q. Pharmaceutical Holding Co., Ltd. may benefit from establishing clear emissions reduction goals and participating in recognised initiatives to enhance its environmental performance and transparency.
How Carbon Intensive is C.Q. Pharmaceutical Holding Co., Ltd.'s Industry?
How Carbon Intensive is C.Q. Pharmaceutical Holding Co., Ltd.'s Location?
C.Q. Pharmaceutical Holding Co., Ltd.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
C.Q. Pharmaceutical Holding Co., Ltd. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
